Next Article in Journal
A Threat- and Efficacy-Based Framework to Understand Confidence in Vaccines among the Public Health Workforce
Next Article in Special Issue
Nonclinical Development of BCG Replacement Vaccine Candidates
Previous Article in Journal / Special Issue
A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence
Vaccines 2013, 1(1), 58-76; doi:10.3390/vaccines1010058

Notes on Article Versions

Action Date Notes Link
article pdf uploaded. 25 January 2013 09:43 CET Version of Record http://www.mdpi.com/2076-393X/1/1/58/pdf-vor
article pdf uploaded. 30 January 2013 09:47 CET Updated version of record http://www.mdpi.com/2076-393X/1/1/58/pdf
article html file updated 7 February 2013 18:00 CET Original file -
article html file updated 8 February 2013 09:40 CET Update -
article xml file uploaded 16 December 2014 04:58 CET Original file -
article html file updated 16 December 2014 04:58 CET Update -
article html file updated 17 June 2015 05:48 CEST Update -
article xml file uploaded 2 July 2015 06:38 CEST Update http://www.mdpi.com/2076-393X/1/1/58/xml
article html file updated 2 July 2015 06:38 CEST Update http://www.mdpi.com/2076-393X/1/1/58/html
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert